Ignite Creation Date:
2024-05-05 @ 9:57 AM
Last Modification Date:
2024-10-26 @ 9:02 AM
Study NCT ID:
NCT00002067
Status:
COMPLETED
Last Update Posted:
2007-10-02
First Post:
1999-11-02
Brief Title:
A Study Comparing Megestrol Acetate at 800 mgDay and Placebo in AIDS Patients With Anorexia and Cachexia
Sponsor:
Bristol-Myers Squibb
Organization:
Bristol-Myers Squibb
Study Overview
Official Title:
Phase III Randomized Double-Blind Study Comparing Megestrol Acetate at 800 mgDay and Placebo in AIDS Patients With Anorexia and Cachexia
Status:
COMPLETED
Status Verified Date:
2007-10
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
No
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
To compare the effects of megestrol acetate and placebo on body weight anorexia cachexia calorie intake and nutritional parameters of patients with a confirmed diagnosis of AIDS To determine whether megestrol acetate relative to placebo improves the perception of well-being among AIDS patients with cachexia To evaluate megestrol acetates effect on immune function via skin test reactivity T4T8 ratio and total lymphocytes
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None
Secondary IDs
| Secondary ID | Type | Domain | Link |
|---|---|---|---|
| MEG8809 | None | None | None |